Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Psychotherapy versus waiting list for common mental disorders in Danish primary care

Official title: The Effectiveness of Psychological Interventions for Common Mental Disorders (EPIC): A Randomized Waitlist-controlled Superiority Trial.

Run by University of Copenhagen · NCT06916429 · Data updated 2026-11-12

This study will test whether psychotherapy in Danish primary care reduces symptoms of depression, anxiety, and related stress more than being on a waiting list for treatment.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment308 (estimated)
SponsorUniversity of Copenhagen
Academic / other
Locations1 site (Copenhagen, Central Region)
StatusRecruiting
StartedApril 1, 2025
Main results expectedOctober 1, 2026
Study endsApril 30, 2027
Registry record updatedOctober 6, 2025
Trial IDNCT06916429 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults in Denmark referred for psychotherapeutic treatment in the primary sector who read and speak Danish and agree to randomization are ideal candidates.

Probably not a fit

Patients judged by their therapist to be unfit for participation or who require urgent psychological or medical care are excluded and unlikely to benefit from this trial.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized controlled trial comparing approximately four months of psychotherapeutic treatment to a waiting-list control among clients referred to the Danish primary sector for common mental disorders. The primary outcome is symptom level on the PHQ-ADS measured about four and a half months after randomization, with additional follow-ups at about eight and 16 months. The trial also explores which client and therapy characteristics (including therapeutic alliance measured after ~5 weeks) predict treatment response and symptom change in the waitlist group. Practicing primary-sector psychologists with typical waiting times participate in delivering the interventions.

Why it matters

Potential benefit: If successful, the study could support offering timely psychotherapy in primary care to reduce depression, anxiety, and stress symptoms more effectively than delayed treatment.

How similar studies have gone: Previous randomized trials have generally shown psychotherapeutic interventions outperform waiting lists for depression and anxiety, and this trial applies that comparison in a Danish primary-care setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Clients:

* All clients who meet the criteria for one of the eleven referral reasons for psychotherapeutic treatment in the Danish primary sector.
* Clients who read and speak proficient Danish to fill in the questionnaires.
* Clients who agree to be randomized through their informed consent.

Psychologists:

* All practicing psychologists employed by the Danish primary sector.
* Psychologists who can commit to the deadlines for beginning treatment.
* Psychologists with at waiting time of approximately four months or longer.

Exclusion Criteria:

\- Clients considered unfit for participation or urgently needing psychological or medical help, as determined by the therapist.

Where it's running

  • University of Copenhagen
    Copenhagen, Central Region, Denmark
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.